A Randomized, Double-Blind, Placebo-Controlled Phase III Study of ODM-201 Versus Placebo in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Patients... Read more about A Randomized, Double-Blind, Placebo-Controlled Phase III Study of ODM-201 Versus Placebo in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Patients...
Optimization of Prostate-Specific Membrane Antigen-Targeted Radiation Read more about Optimization of Prostate-Specific Membrane Antigen-Targeted Radiation
NRG Oncology Network Group Operations Center Read more about NRG Oncology Network Group Operations Center
A Single-Arm, Phase 2 Study to Evaluate the Safety and Efficacy of VT-464 in Patients with Castration-Resistant Prostate Cancer Progressing on Enzalutimide or Abriaterone Read more about A Single-Arm, Phase 2 Study to Evaluate the Safety and Efficacy of VT-464 in Patients with Castration-Resistant Prostate Cancer Progressing on Enzalutimide or Abriaterone
The Impact of Community-Based Organization in Providing Arts Instruction to Disadvantaged Students Read more about The Impact of Community-Based Organization in Providing Arts Instruction to Disadvantaged Students
Regulation of Nephron Progenitor Cell Lifespan by Energy Metabolism Read more about Regulation of Nephron Progenitor Cell Lifespan by Energy Metabolism
FN2102 A randomized, prospective, double-blind, placebo controlled, phase 3 study of study drug prophylaxis as a supplement to standard of care prophylaxis to prevent Read more about FN2102 A randomized, prospective, double-blind, placebo controlled, phase 3 study of study drug prophylaxis as a supplement to standard of care prophylaxis to prevent
